New drugs that spur weight loss and treat diabetes have been taking the public—along with the pharmaceutical market—by storm. The most up-to-date entrant, Zepbound, a short while ago joined Ozempic, Wegovy, Victoza and others in a increasing class of medication known as GLP-1 receptor agonists.Disclaimer: Health care News Now has made each work… Read More